Literature DB >> 17932356

Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.

Helge Lind1, Per Olaf Ekstrøm, David Ryberg, Vidar Skaug, Tove Andreassen, Lodve Stangeland, Aage Haugen, Shanbeh Zienolddiny.   

Abstract

Mutations in the TP53 gene are important events during human lung carcinogenesis. The TP53 gene harbors several polymorphisms, and functional studies have shown that the Arg72Pro polymorphism alters both wild-type and mutant p53 protein activity. Thus, we hypothesized that certain Arg72Pro genotypes may influence the frequency and pattern of somatic mutations in TP53. We therefore examined the status of the Arg72Pro polymorphism and TP53 mutations in 260 non-small-cell lung cancer cases. Here we report a significant trend toward lower frequency of TP53 mutations with increasing number of Pro72 alleles (P = 0.02). Overall, Pro72 allele carriers had significantly lower frequency of TP53 mutations compared with Arg72 homozygotes (P = 0.02). In addition, carriage of the Pro72 variant was related to a lower frequency of mutations affecting the hotspot codon 273. Mutations at codon 273 accounted for 10.6% of the mutations in Arg72 homozygotes and 1.7% of the mutations in Pro72 allele carriers. Our results suggest that the genotype of the Arg72Pro polymorphism may modulate the frequency of TP53 mutations in non-small-cell lung cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932356     DOI: 10.1158/1055-9965.EPI-07-0153

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  9 in total

1.  Analysis of mutational spectra by denaturing capillary electrophoresis.

Authors:  Per O Ekstrøm; Konstantin Khrapko; Xiao-Cheng Li-Sucholeiki; Ian W Hunter; William G Thilly
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

Authors:  Matheus F Bezerra; Juan L Coelho-Silva; Jessica C Nascimento; Mariana T Benicio; Cintia R Rocha; Cintia G Machado; Eduardo M Rego; Marcos A Bezerra; Antonio R Lucena-Araujo; Eduardo I Beltrão
Journal:  Haematologica       Date:  2016-10-20       Impact factor: 9.941

3.  The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC.

Authors:  Chunbo Wang; Huan Nie; Yiqun Li; Guiyou Liu; Xu Wang; Shijie Xing; Liping Zhang; Xin Chen; Yue Chen; Yu Li
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

Review 4.  Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer.

Authors:  Shanbeh Zienolddiny; Vidar Skaug
Journal:  Lung Cancer (Auckl)       Date:  2011-12-29

5.  Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore.

Authors:  Hui Wan Chua; Daniel Ng; Serena Choo; San San Lum; Huihua Li; Li Ying Soh; Kanaga Sabapathy; Adeline Seow
Journal:  BMC Cancer       Date:  2010-03-10       Impact factor: 4.430

6.  Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.

Authors:  Johanna Samulin Erdem; Vidar Skaug; Per Bakke; Amund Gulsvik; Aage Haugen; Shanbeh Zienolddiny
Journal:  BMC Cancer       Date:  2016-01-19       Impact factor: 4.430

Review 7.  Genetic predisposition to lung cancer: comprehensive literature integration, meta-analysis, and multiple evidence assessment of candidate-gene association studies.

Authors:  Junjun Wang; Qingyun Liu; Shuai Yuan; Weijia Xie; Yuan Liu; Ying Xiang; Na Wu; Long Wu; Xiangyu Ma; Tongjian Cai; Yao Zhang; Zhifu Sun; Yafei Li
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

8.  TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.

Authors:  Tahsin Nairuz; Mostafijur Rahman; Most Umme Bushra; Yearul Kabir
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

9.  Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer.

Authors:  Johanna Samulin Erdem; Vidar Skaug; Aage Haugen; Shanbeh Zienolddiny
Journal:  J Cancer       Date:  2016-02-05       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.